T1001	food 30 40	wheat bran
T1003	drug 109 116	digoxin
T1005	drug 359 366	digoxin
T1007	food 446 456	wheat bran
T1008	drug 459 466	digoxin
T1009	drug 488 495	digoxin
T10012	interaction 552 559	reduced
T10013	drug 564 571	digoxin
T10015	drug 804 811	digoxin
T10018	studyType 176 192	randomized study
T10019	food 221 243	gel-forming wheat bran
T10020	food 285 306	ispaghula formulation
T10021	food 50 82	bulk-forming ispaghula cathartic
T10022	food 251 280	nongel-forming bulk cathartic
T10023	parameter 370 376	plasma
T10024	food 476 485	ispaghula
T10025	duration 497 508	for 4 weeks
T10026	food 641 650	Ispaghula
T10027	interaction 655 667	no influence
T10028	food 729 750	ispaghula formulation
T10029	population 822 840	geriatric patients
T10030	pharmacokinetics 328 355	steady state concentrations
T2006	population 380 404	30 geriatric in-patients
T20011	food 541 551	wheat bran
T20014	food 710 720	wheat bran
T20017	population 120 141	geriatric in-patients
T20010	drug 50 82	bulk-forming ispaghula cathartic
T20020	drug 266 280	bulk cathartic
T20021	drug 308 319	Vi-Siblin S
T20023	drug 476 485	ispaghula
T20024	value 605 639	still within the therapeutic range
T20026	drug 641 650	Ispaghula
T20022	drug 285 306	ispaghula formulation
T20028	drug 729 750	ispaghula formulation
T20030	duration 510 539	After 2 but not after 4 weeks
T2002	pharmacokinetics 90 105	bioavailability
T20016	pharmacokinetics 812 818	levels
T1	pertinence 0 16	Title (3038494):
#1	AnnotatorNotes T1	On se pose la question de la pertinence de cet article 
R1	decrease_pharmacokinetic_parameter Arg1:T20011 Arg2:T10013	
